Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 118,085	$ 102,546	$ 62,713
General and administrative	25,985	23,589	20,921
Total operating expenses	144,070	126,135	83,634
Loss from operations	(144,070)	(126,135)	(83,634)
Interest and other income, net	5,644	8,880	1,806
Net loss	(138,426)	(117,255)	(81,828)
Other comprehensive loss:
Unrealized gain on investments, net		1	9
Comprehensive loss	$ (138,426)	$ (117,254)	$ (81,819)
Net loss per common share, basic	$ (3.83)	$ (3.44)	$ (2.80)
Net loss per common share, diluted	$ (3.83)	$ (3.44)	$ (2.80)
Weighted-average number of common shares used to compute basic net loss per common share	36,105,671	34,106,923	29,271,777
Weighted-average number of common shares used to compute diluted net loss per common share	36,105,671	34,106,923	29,271,777